Acadia Pharmaceuticals

ACAD

30.75

+1.82

+6.3%

Please Login or Register

Login|Register FREE

Stock Price
Open: 29.10
Prev. Close: 28.93
Low/Hi: 28.84 - 30.90
52-Week: 25.06 - 41.20
Volumes
Equity: 2,204,302
90-Day Avg: 1,573,621
Option: 2,869
90-Day Avg: 2,231
Volatility
Todays Stock Vol: 85.6
20-Day (HV): 46.1
52-Week (HV): 41.4
30-Day IV: 53.1 -2.2
IV Pct Rank: 47% Moderate
Fundamental
Div. Yield:
Earnings: 1-Mar (Est.)
P/E Ratio:
Market Cap: 3.6 B
Short Int Pct: 0.0%
Pct Held By Inst.: 97.7%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

ACAD Company Events

Upcoming Events
Event Event Date Location Info
No Upcoming Events
Past Events
Event Event Date Location Info
36th Annual J.P. Morgan Healthcare Conference Jan 9, 2018
29th Annual Piper Jaffray Healthcare Conference Nov 28, 10:00 AM
Ladenburg Thalmann 2017 Healthcare Conference Sep 26, 10:00 AM
Bank of America Merrill Lynch 2017 Healthcare Conference May 16, 2017
Needham & Companys 16th Annual Healthcare Conference Apr 5, 10:40 AM
Cowen and Company 37th Annual Health Care Conference Mar 6, 1:20 PM
35th Annual J.P. Morgan Healthcare Conference Jan 10, 2017 San Francisco
Ladenburg Thalmann 2016 Healthcare Conference Sep 27, 2016
Caregiver Summit Sep 20, 2016
Morgan Stanley Global Healthcare Conference Sep 12, 2016 New York City
JMP Securities Life Sciences Conference Jun 21, 2016
ACADIA Pharmaceuticals Inc Annual Shareholders Meeting Jun 10, 11:00 AM
Goldman Sachs 37th Annual Global Healthcare Conference Jun 8, 2016 Rancho Palos Verdes, California.
Goldman Sachs Global Healthcare Conference Jun 8, 6:20 PM
Bank of America Merrill Lynch 2016 Health Care Conference May 11, 2016 Las Vegas.
ACADIA Pharmaceuticals Inc to discuss the FDA approval of NUPLAZID May 2, 8:30 AM
Advisory Committee Meeting May 1, 2016
i

Parkinsons disease psychosis is a debilitating condition for which there are no FDA-approved treatment options available to patients, said Steve Davis, ACADIAs President and Chief Executive Officer. We look forward to discussing our data from the NUPLAZID clinical program with the members of the Committee.

The Prescription Drug User Fee Act (PDUFA) action date for completion of FDA review of the NUPLAZID NDA May 1, 2016
15th Annual Needham Healthcare Conference Apr 12, 2016 New York City.
Cowen Health Care Conference Mar 8, 2016
LEERINK Partners 5th Annual Global Healthcare Conference Feb 10, 2016 New York City.
i

biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced that it will present

34th Annual J.P. Morgan Healthcare Conference Jan 12, 11:30 AM San Francisco.
i

A live webcast of ACADIAs presentation will be accessible on the companys website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website through January 26, 2016.

24th Annual Credit Suisse Healthcare Conference Nov 10, 1:30 PM
JMP Securities Life Sciences Conference in New York Jun 24, 11:00 AM
Bank of America Merrill Lynch 2015 Health Care Conference May 13, 7:20 PM

Wait, Before You Leave...

Want to Know More About ACAD Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon